Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Parissa K. Ferguson, MS

Advertisement

Articles by Parissa K. Ferguson, MS

Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer

ByAjaz Bulbul, MD,Patrick M. Forde, MD,Ayesha Murtuza, MD,Brian Woodward,Hannah Yang,Ingmar Bastian,Parissa K. Ferguson, MS,Fernando Lopez-Diaz, PhD,David S. Ettinger, MD,Hatim Husain, MD
April 15th 2018

In this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.

Advertisement

Latest Updated Articles

  • Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer
    Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer

    April 15th 2018



Advertisement
Advertisement

Trending on CancerNetwork

1

Setting Up an HDR Brachytherapy Program Amid a National Decline

2

Zamto-Cel Improves EFS vs R-GemOx in Transplant-Ineligible R/R LBCL

3

Biomarker Sequencing, PD-L1 Status, and FLOT Dosing in Gastroesophageal Cancer

4

CD38-Targeted Immuno-PET Helps Detect Active Multiple Myeloma

5

16-Fraction PMRT With IMN Irradiation Noninferior in High-Risk Breast Cancer

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us